CABA
Cabaletta Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.48
+4.96%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-86.1%
Return on equity
-70.6%
Return on assets
-78.5%
Return on invested capital
0.00x
Asset turnover
-$153.9M
Cash from operations
$1.33
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026